Gabbita, S. ., Aksenov, M. ., Lovell, M. ., & Markesbery, W. . (1999). Decrease in peptide methionine sulfoxide reductase in Alzheimer’s disease brain. Journal of Neurochemistry, 73(4), 1660-6. https://doi.org/10.1046/j.1471-4159.1999.0731660.x

Lovell, M. ., Xie, C. ., & Markesbery, W. . (2000). Decreased base excision repair and increased helicase activity in Alzheimer’s disease brain. Brain Research, 855(1), 116-23. https://doi.org/10.1016/s0006-8993(99)02335-5 (Original work published 2000)

Lovell, M. ., Xie, C. ., Gabbita, S. ., & Markesbery, W. . (2000). Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer’s disease brain. Free Radical Biology & Medicine, 28(3), 418-27. https://doi.org/10.1016/s0891-5849(99)00258-0 (Original work published 2000)

Xie, C. ., Markesbery, W. ., & Lovell, M. . (2000). Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium. Free Radical Biology & Medicine, 28(5), 665-72. https://doi.org/10.1016/s0891-5849(99)00268-3 (Original work published 2000)

Lovell, M. ., Xie, C. ., & Markesbery, W. . (2000). Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radical Biology & Medicine, 29(8), 714-20. https://doi.org/10.1016/s0891-5849(00)00346-4 (Original work published 2000)

Lovell, M. ., Xie, C. ., & Markesbery, W. . (1969). Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures. Neurobiology of Aging, 22(2), 187-94. https://doi.org/10.1016/s0197-4580(00)00235-9 (Original work published 1969)

Lange, M. B., St Clair, D. ., Markesbery, W. ., Studzinski, C. ., Murphy, M. ., & Butterfield, D. . (2010). Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease. Neurobiology of Disease, 38(1), 104-15. https://doi.org/10.1016/j.nbd.2010.01.004

Keller, J. ., Schmitt, F. ., Scheff, S. ., Ding, Q. ., Chen, Q. ., Butterfield, D. ., & Markesbery, W. . (2005). Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology, 64(7), 1152-6. https://doi.org/10.1212/01.WNL.0000156156.13641.BA (Original work published 2005)

Sultana, R. ., Boyd-Kimball, D. ., Poon, H. ., Cai, J. ., Pierce, W. ., Klein, J. ., … Butterfield, D. . (2006). Oxidative modification and down-regulation of Pin1 in Alzheimer’s disease hippocampus: A redox proteomics analysis. Neurobiology of Aging, 27(7), 918-25. https://doi.org/10.1016/j.neurobiolaging.2005.05.005

Sultana, R. ., Boyd-Kimball, D. ., Poon, H. ., Cai, J. ., Pierce, W. ., Klein, J. ., … Butterfield, D. . (2006). Redox proteomics identification of oxidized proteins in Alzheimer’s disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiology of Aging, 27(11), 1564-76. https://doi.org/10.1016/j.neurobiolaging.2005.09.021